• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动患者的阻塞性睡眠呼吸暂停:波兰人群患者的患病率、决定因素及临床特征

Obstructive sleep apnoea in patients with atrial fibrillation: prevalence, determinants and clinical characteristics of patients in Polish population.

作者信息

Szymański Filip M, Płatek Anna E, Karpiński Grzegorz, Koźluk Edward, Puchalski Bartosz, Filipiak Krzysztof J

机构信息

I Katedra i Klinika Kardiologii, Warszawski Uniwersytet Medyczny, Warszawa.

出版信息

Kardiol Pol. 2014;72(8):716-24. doi: 10.5603/KP.a2014.0070. Epub 2014 Mar 27.

DOI:10.5603/KP.a2014.0070
PMID:24671917
Abstract

BACKGROUND

Obstructive sleep apnoea (OSA) and atrial fibrillation (AF) are two conditions highly prevalent in the general population. OSA is known to cause haemodynamic changes, oxidative stress, and endothelial damage, and therefore promote vascular and heart remodelling which results in AF triggering and exacerbation. Coexistence of OSA and AF influences the course of both diseases, and therefore should be taken into consideration in patient management strategy planning.

AIM

To assess the prevalence of OSA in Polish AF patients, and to describe the clinical characteristics of patients with concomitant OSA and AF.

METHODS

We enrolled into the study 289 consecutive patients hospitalised in a tertiary, high-volume Cardiology Department with a primary diagnosis of AF. In addition to standard examination, all patients underwent an overnight sleep study to diagnose OSA, which was defined as apnoea-hypopnoea index (AHI) ≥ 5 per hour.

RESULTS

After applying exclusion criteria, the final analysis covered 266 patients (65.0% male, mean age 57.6 ± 10.1 years). OSA was present in 121 (45.49%) patients. Patients with OSA were older (59.6 ± 8.0 vs. 56.0 ± 11.4 years; p = 0.02), had higher body mass index (BMI; 30.9 ± 5.4 vs. 28.7 ± 4.4 kg/m²; p < 0.01) larger neck size (41.2 ± 3.8 vs. 39.3 ± 3.3 cm; p = 0.0001) and waist circumference (108.5 ± 13.1 vs. 107.7 ± 85.4 cm; p < 0.0001) than patients without OSA. There were no significant differences between the groups in terms of systolic and diastolic blood pressure or history of comorbidities (p > 0.05). OSA patients were less likely than non-OSA patients to have paroxysmal AF (62.0% vs. 75.9%; p = 0.02). Dividing newly diagnosed OSA patients according to the disease severity showed that mild OSA (AHI ≥ 5/h and < 15/h) was present in 27.82% of the study population, moderate OSA (AHI ≤ 15/h and ≥ 30/h) in 13.16% of patients, and severe OSA (> 30/h) in 4.51% of patients. No significant differences in terms of comorbidities and anthropometric features were seen between mild and moderate, between moderate and severe, and between mild and severe OSA.

CONCLUSIONS

OSA is highly prevalent in patients with AF in the Polish population, and affects approximately half of the patients. OSA patients are more likely to be older, have higher BMI, and greater waist and neck circumference. Persistent AF is the most common form of the arrhythmia in patients with OSA, while patients without OSA are more likely to have paroxysmal AF.

摘要

背景

阻塞性睡眠呼吸暂停(OSA)和心房颤动(AF)是普通人群中高度常见的两种病症。已知OSA会引起血流动力学变化、氧化应激和内皮损伤,从而促进血管和心脏重塑,进而导致AF的触发和加重。OSA与AF并存会影响两种疾病的病程,因此在患者管理策略规划中应予以考虑。

目的

评估波兰AF患者中OSA的患病率,并描述合并OSA和AF患者的临床特征。

方法

我们纳入了连续289例在一家大型三级心脏病科住院的患者,其初步诊断为AF。除了标准检查外,所有患者均接受了整夜睡眠研究以诊断OSA,OSA定义为呼吸暂停低通气指数(AHI)≥5次/小时。

结果

应用排除标准后,最终分析涵盖266例患者(男性占65.0%,平均年龄57.6±10.1岁)。121例(45.49%)患者存在OSA。与无OSA的患者相比,OSA患者年龄更大(59.6±8.

相似文献

1
Obstructive sleep apnoea in patients with atrial fibrillation: prevalence, determinants and clinical characteristics of patients in Polish population.心房颤动患者的阻塞性睡眠呼吸暂停:波兰人群患者的患病率、决定因素及临床特征
Kardiol Pol. 2014;72(8):716-24. doi: 10.5603/KP.a2014.0070. Epub 2014 Mar 27.
2
Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients.严重阻塞性睡眠呼吸暂停患者中房颤消融的疗效不佳。
Europace. 2010 Aug;12(8):1084-9. doi: 10.1093/europace/euq128. Epub 2010 May 20.
3
Presence and severity of obstructive sleep apnea and remote outcomes of atrial fibrillation ablations - a long-term prospective, cross-sectional cohort study.阻塞性睡眠呼吸暂停的存在及严重程度与心房颤动消融的远期结局——一项长期前瞻性横断面队列研究
Sleep Breath. 2015 Sep;19(3):849-56. doi: 10.1007/s11325-014-1102-x. Epub 2015 Jan 8.
4
Prevalence and characteristics of OSAFED syndrome in atrial fibrillation primary care patients.心房颤动初级保健患者中OSAFED综合征的患病率及特征
Kardiol Pol. 2017;75(5):432-438. doi: 10.5603/KP.a2017.0023. Epub 2017 Feb 9.
5
Obstructive sleep apnea is common and independently associated with atrial fibrillation in patients with hypertrophic cardiomyopathy.阻塞性睡眠呼吸暂停在肥厚型心肌病患者中很常见,并与心房颤动独立相关。
Chest. 2010 May;137(5):1078-84. doi: 10.1378/chest.09-2335. Epub 2010 Feb 12.
6
Sleep apnoea has a dose-dependent effect on atrial remodelling in paroxysmal but not persistent atrial fibrillation: a high-density mapping study.睡眠呼吸暂停对阵发性而非持续性心房颤动的心房重构具有剂量依赖性影响:高密度标测研究。
Europace. 2021 May 21;23(5):691-700. doi: 10.1093/europace/euaa275.
7
Implication of Apnea-Hypopnea Index, a Measure of Obstructive Sleep Apnea Severity, for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.阻塞性睡眠呼吸暂停严重程度指标——呼吸暂停低通气指数对肥厚型心肌病合并心房颤动患者的影响。
J Am Heart Assoc. 2020 Apr 21;9(8):e015013. doi: 10.1161/JAHA.119.015013. Epub 2020 Apr 16.
8
Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation.体重指数、阻塞性睡眠呼吸暂停与心房颤动导管消融的结果
J Cardiovasc Electrophysiol. 2008 Jul;19(7):668-72. doi: 10.1111/j.1540-8167.2008.01118.x. Epub 2008 Mar 21.
9
Association of atrial fibrillation and obstructive sleep apnea.心房颤动与阻塞性睡眠呼吸暂停的关联。
Circulation. 2004 Jul 27;110(4):364-7. doi: 10.1161/01.CIR.0000136587.68725.8E. Epub 2004 Jul 12.
10
The prevalence of obstructive sleep apnea in patients with atrial fibrillation.心房颤动患者中阻塞性睡眠呼吸暂停的患病率。
Clin Cardiol. 2018 May;41(5):601-607. doi: 10.1002/clc.22933. Epub 2018 May 10.

引用本文的文献

1
Prevalence and risk factors for persistent atrial fibrillation in obstructive sleep apnea.阻塞性睡眠呼吸暂停患者持续性心房颤动的患病率及危险因素
Sleep Sci. 2022 Oct-Dec;15(4):448-452. doi: 10.5935/1984-0063.20220077.
2
The mobile sleep medicine model in neurologic practice: Rationale and application.神经科实践中的移动睡眠医学模式:基本原理与应用
Front Neurol. 2022 Oct 28;13:1032463. doi: 10.3389/fneur.2022.1032463. eCollection 2022.
3
Role of Obstructive Sleep Apnea in Cognitive Impairment.阻塞性睡眠呼吸暂停在认知障碍中的作用。
Int J Head Neck Surg. 2019 Jul-Sep;10(3):57-61. doi: 10.5005/jp-journals-10001-1373.
4
Heart failure and central sleep apnea in the era of implantable recorders.植入式记录器时代的心力衰竭和中枢性睡眠呼吸暂停。
Anatol J Cardiol. 2021 Apr;25(4):216-224. doi: 10.5152/AnatolJCardiol.2021.63668.
5
Low-Level Vagus Nerve Stimulation Reverses Obstructive Sleep Apnea-Related Atrial Fibrillation by Ameliorating Sympathetic Hyperactivity and Atrial Myocyte Injury.低水平迷走神经刺激通过改善交感神经过度兴奋和心房肌细胞损伤来逆转阻塞性睡眠呼吸暂停相关的心房颤动。
Front Physiol. 2021 Jan 26;11:620655. doi: 10.3389/fphys.2020.620655. eCollection 2020.
6
The why, when and how to test for obstructive sleep apnea in patients with atrial fibrillation.在房颤患者中检测阻塞性睡眠呼吸暂停的原因、时机和方法。
Clin Res Cardiol. 2018 Aug;107(8):617-631. doi: 10.1007/s00392-018-1248-9. Epub 2018 Apr 12.
7
Predictors of heart rhythm disturbances in hypertensive obese patients with obstructive sleep apnea.阻塞性睡眠呼吸暂停的高血压肥胖患者心律失常的预测因素
J Geriatr Cardiol. 2017 Sep;14(9):553-562. doi: 10.11909/j.issn.1671-5411.2017.09.010.
8
Management of Patients with Atrial Fibrillation: Focus on Treatment Options.心房颤动患者的管理:聚焦治疗选择
J Atr Fibrillation. 2016 Oct 31;9(3):1450. doi: 10.4022/jafib.1450. eCollection 2016 Oct-Nov.
9
Stratification of cardiovascular risk in patients with atrial fibrillation and obstructive sleep apnea-validity of the 2MACE score.心房颤动合并阻塞性睡眠呼吸暂停患者心血管风险分层——2MACE评分的有效性
Sleep Breath. 2017 Sep;21(3):601-606. doi: 10.1007/s11325-017-1469-6. Epub 2017 Feb 2.
10
Stroke risk assessment in atrial fibrillation: risk factors and markers of atrial myopathy.心房颤动的卒中风险评估:心房心肌病的危险因素和标志物。
Nat Rev Cardiol. 2016 Sep;13(9):549-59. doi: 10.1038/nrcardio.2016.106. Epub 2016 Jul 7.